We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The FDA cited six devicemakers for a range of GMP and other failures, including root-cause analysis for nonconforming products and lax environmental controls. Read More
The FDA slapped Henan Kangdi Medical Devices with a warning letter over repeat CGMP failures at its Zhoukou, Henan facility, including a lack of testing. Read More
The company said it had managed installations of the Pixel Shine software for evaluation by potential customers but it lacked documentation for the installations. Read More
An FDA inspection of Medical Informatics’ Houston, Texas facility revealed lax complaint handling and a lack of medical device reporting procedures.
Read More
Westwood Laboratories didn’t establish corrective and preventive action procedures for nonconforming products, according to a 483 received following an inspection of the firm’s Azusa, California plant.
Read More
Algomedica’s Sunnyvale, California facility drew a Form 483 when an inspection revealed a pattern of failing to address root causes of nonconformance of its artificial intelligence algorithm PixelShine that analyzes CT scans. Read More
The FDA slapped Henan Kangdi Medical Devices with a warning letter over repeat CGMP failures at its Zhoukou, Henan facility, including a lack of testing.
Read More